Last reviewed · How we verify
Whole blood transfusion — Competitive Intelligence Brief
phase 3
Hematology
Biologic
Live · refreshed every 30 min
Target snapshot
Whole blood transfusion (Whole blood transfusion) — Oregon Health and Science University. Whole blood transfusion involves the transfer of whole blood from a donor into a patient to restore blood volume and red blood cell count.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Whole blood transfusion TARGET | Whole blood transfusion | Oregon Health and Science University | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Whole blood transfusion CI watch — RSS
- Whole blood transfusion CI watch — Atom
- Whole blood transfusion CI watch — JSON
- Whole blood transfusion alone — RSS
Cite this brief
Drug Landscape (2026). Whole blood transfusion — Competitive Intelligence Brief. https://druglandscape.com/ci/whole-blood-transfusion. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab